483
Suresh Anne, M.D.Suresh Anne, M.D. – FDA 483, Feb 13, 2026
Record Details
An FDA inspection of Suresh Anne, M.D., a clinical investigator in Flint, MI, revealed significant deviations from investigational plans and protocols. The firm failed to enroll eligible subjects and did not follow required safety monitoring procedures for investigational products. Additionally, the investigator did not promptly report non-serious adverse events to the sponsor as required by the study protocol.
View Company Profile
ID · 42c11be6-f2e0-4338-920b-39468eb38f62
Other documents for Suresh Anne, M.D.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.